Africa to receive '100,000 mpox vaccines' from Germany
Germans army has stockpiled "117,000 doses of Jynneos" since 2022
BERLIN: Germany will donate 100,000 mpox vaccine doses from its military stocks to help contain the outbreak on the African continent in the short term and help the affected countries, said a government spokesperson on Monday.
The government will provide the World Health Organization (WHO) with flexible financial resources via various instruments to combat mpox and also support its partners in Africa through the GAVI vaccination alliance, added the spokesperson.
Germany has around "117,000 doses of Jynneos", which is being stockpiled by the German army after Berlin procured it in 2022.
It will keep a minimum amount of stock, to protect travelling authorities, for example, said a defence ministry spokesperson on Monday. He added that a separate decision would need to be made when it comes to reordering vaccines.
WHO has declared mpox a global public health emergency after an outbreak in the Democratic Republic of the Congo spread to neighbouring countries and a new form of the virus, clade Ib, triggered concerns about the speed of transmission.
The government was looking at the quickest way to get the vaccines to the affected countries, primarily the Democratic Republic of Congo, but also Burundi and neighbouring countries in East Africa, according to a foreign ministry spokesperson.
-
CDC monitors travelers from Siberia after plague worker’s death, director says
-
Russia pushes back on plague death reports, defends WHO notification
-
WHO deems Russia plague risk 'low' following lab technician’s fatal illness
-
New York declares Measles state of emergency amid nationwide disease resurgence
-
First-of-its-kind treatment shrinks unborn baby’s tumour before birth
-
France steps up Ebola support in Congo as fears of resurgence grow
-
Vance’s fraud crackdown may raise health insurance costs for Americans
-
One common mistake elevates blood pressure readings by 7 points, study warns
-
Moderna loses US government license defense in patent case
-
Novo says new Ozempic shows lower cardiovascular risk compared with Lilly’s Mounjaro
-
University of Nottingham researchers say new gel could regrow tooth enamel in weeks
-
New Chinese drug extends stroke treatment window from hours to 2 days: study finds